|
|
|
|
|||||
|
|
|
 | |||||||||||||||||||||||||||||
| Group: | Order: | Settings | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| No. | Name | Market Cap. | P/E | Forward P/E | PEG | P/S | P/B | P/Cash | P/Free Cash Flow |
| Dividend Yield | EPS growth past 5 years | EPS growth next 5 years | Sales growth past 5 years | Float Short | Performance (Week) | Performance (Month) | Performance (Quarter) | Performance (Half Year) | Performance (Year) |
| Performance (Year To Date) | Analyst Recom. | Average Volume | Relative Volume | Change | Volume | Number of Stocks |
| Overview | Valuation | Performance | Custom | Bar Chart | Spectrum | Charts |
| Name | Market Cap | P/E | Fwd P/E | Dividend | Sales past 5Y |  Perf Week |
Avg Volume | Rel Volume | Change | Volume | Stocks |
| Consumer Cyclical | 5856.72B | 21.94 | 12.52 | 0.91% | 21.09% | 4.62% | 1.46B | 1.48 | 3.92% | 2.16B | 582 |
| Communication Services | 5386.72B | 18.97 | 15.37 | 0.99% | 18.18% | 3.50% | 752.54M | 1.58 | 4.78% | 1.19B | 290 |
| Healthcare | 7567.95B | 24.65 | 15.99 | 1.53% | 15.41% | 2.73% | 1.19B | 1.66 | 2.65% | 1.97B | 1317 |
| Utilities | 1501.50B | 23.69 | 3.59 | 3.34% | 5.60% | 2.22% | 173.21M | 1.44 | 2.40% | 249.46M | 115 |
| Technology | 11359.35B | 26.87 | 19.90 | 1.04% | 15.34% | 2.15% | 1.46B | 1.46 | 4.97% | 2.13B | 796 |
| Basic Materials | 1978.43B | 9.54 | 12.29 | 3.42% | 12.33% | 2.11% | 469.02M | 1.21 | 2.36% | 567.72M | 256 |
| Real Estate | 1502.60B | 23.69 | 27.64 | 3.75% | 9.83% | 2.04% | 350.81M | 1.33 | 2.33% | 466.76M | 270 |
| Consumer Defensive | 3784.51B | 25.84 | 22.47 | 2.46% | 5.22% | 1.88% | 314.05M | 2.16 | 1.82% | 679.05M | 249 |
| Financial | 9045.67B | 13.98 | 12.77 | 2.24% | 7.25% | 1.64% | 877.74M | 1.47 | 1.83% | 1.29B | 1215 |
| Industrials | 4767.73B | 20.71 | 18.18 | 1.60% | 5.82% | 1.25% | 568.45M | 1.23 | 1.99% | 698.42M | 646 |
| Energy | 3781.00B | 7.65 | 7.64 | 5.82% | 11.45% | -0.31% | 681.66M | 1.26 | 1.07% | 857.83M | 267 |
| export |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite